ABBY MARTENS: Open Payments
NPI 1821682238 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 41 payments from 17 companies in 2025. Trend: 2023 $5,411 · 2024 $539 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $164 |
| Iovance Biotherapeutics, Inc. | 5 | $75 |
| GENZYME CORPORATION | 3 | $56 |
| Janssen Biotech, Inc. | 3 | $54 |
| JAZZ PHARMACEUTICALS INC. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Geron Corporation | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
Products named: Amtagvi, RYBREVANT, PLUVICTO, Fabhalta, KISQALI, RYTELO, LIBTAYO, DATROWAY.
Industry payments across AR — which companies pay providers there.
